Biomendi S.A.U.

Quick facts

Marketed products

• Intravenous ibuprofen · Pain Management, Inflammation
  Intravenous ibuprofen inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain.

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Biomendi S.A.U. portfolio CI brief
• Biomendi S.A.U. pipeline updates RSS